Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Healthstream (HSTM) over the last 12 years, with Q3 2025 value amounting to $1.3 million.

  • Healthstream's Non-Current Deffered Revenue fell 2286.06% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 2286.06%. This contributed to the annual value of $1.7 million for FY2024, which is 2369.76% down from last year.
  • Per Healthstream's latest filing, its Non-Current Deffered Revenue stood at $1.3 million for Q3 2025, which was down 2286.06% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Healthstream's Non-Current Deffered Revenue peaked at $2.9 million during Q4 2022, and registered a low of $990000.0 during Q1 2022.
  • Over the past 5 years, Healthstream's median Non-Current Deffered Revenue value was $1.7 million (recorded in 2024), while the average stood at $1.8 million.
  • As far as peak fluctuations go, Healthstream's Non-Current Deffered Revenue soared by 15878.79% in 2023, and later tumbled by 3901.46% in 2024.
  • Healthstream's Non-Current Deffered Revenue (Quarter) stood at $1.6 million in 2021, then skyrocketed by 85.53% to $2.9 million in 2022, then dropped by 26.15% to $2.2 million in 2023, then dropped by 23.7% to $1.7 million in 2024, then fell by 22.11% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.2 million for Q2 2025, and $1.3 million during Q1 2025.